The acquisition of FishVet Group (FVG) in 2020 makes PHARMAQ Analytiq one of the sector’s most competent global expert centres in the field of analysis and diagnostics, and more than doubles our capacity in the field of histopathology.
The merger of PHARMAQ Analytiq and FishVet Group has created a world-leading full-service supplier to the aquaculture sector
We are now entering a new era, and FishVet Group is being incorporated under the name of PHARMAQ Analytiq. Our customers will now have access to analyses from our experts in laboratories in Norway, Scotland, Ireland and Chile. At the same time, the new company PHARMAQ Analytiq will be moving its business and service provision to a new customer portal called iWise – yet another tool enabling our customers to benefit from our world-class expertise.
A rapidly growing and challenging market is making ever increasing demands on delivery performance and expertise. We are proud to have now become an even stronger and more relevant partner for the aquaculture sector – sharing the common goal of promoting improved fish health and welfare.
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com. Privacy Policy. Cookie Policy. Terms of Use.
Copyright © 2020 Zoetis LLC. All rights reserved.